Dyax

Shire’s multibillion-dollar gamble on lanadelumab pays off with stellar PhIII data, quick marketing application
Endpoints
Thu, 05/18/17 - 09:38 am
Shire
lanadelumab
DX-2930
HAE
Cinryze
Dyax
Shire Completes Acquisition of Dyax
Yahoo
Fri, 01/22/16 - 10:06 am
Shire
Dyax
M&A
Biotech Investing: This Is Undoubtedly the Craziest Stat You'll Ever See
Motley Fool
Sat, 01/16/16 - 11:41 am
biotech
Dyax
Baxalta
Dyax shares jump as antitrust waiting period for Shire acquisition ends
Marketwatch
Thu, 12/3/15 - 09:29 am
Dyax
Shire
M&A
$5.9 Billion Buyout: 1 Number Underpins Shire's Huge Dyax Bet
Motley Fool
Sat, 11/7/15 - 12:45 pm
M&A
Dyax
Shire
5 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 11/7/15 - 11:38 am
MannKind
ZS Pharma
Xoma
Dyax
Valeant Pharmaceuticals
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
TheStreet.com
Mon, 11/2/15 - 08:10 am
Shire
Dyax
M&A
Dyax banks on drug designation news
Bizjournals.com
Tue, 07/7/15 - 12:28 pm
Dyax
DX-2930
HAE
hereditary angiodema
Dyax's Threat to $630,000 Shire Drug Makes It a Target
Bloomberg
Thu, 06/11/15 - 10:13 am
Shire
Dyax
DX-2930
HAE
hereditary angiodema
Cinryze
Dyax shares jump on drug study, FDA fast-track status
Marketwatch
Tue, 03/31/15 - 05:53 pm
Dyax
FDA
fast track
DX-2930
hereditary angiodema
3 Surging Biotech Stocks to Watch: OncoSec, Clovis, Dyax
Wall St Cheat Sheet
Mon, 03/3/14 - 03:33 pm
OncoSec
Clovis Oncology
Dyax
This Company Is Focused on Delivering Value to Patients and Shareholders
Motley Fool
Sun, 10/6/13 - 09:19 am
Dyax
DX-2930
angioedema
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
An Interesting Bio Play in the Blood Disorder Niche
Motley Fool
Tue, 07/2/13 - 01:39 am
hereditary angiodema
Dyax
Shire
CSL
ViroPharma
Biovitrum
Halozyme
Cinryze
[video]3 Biggest Biotech Crashes in April
Motley Fool
Thu, 05/2/13 - 10:36 am
Dyax
Rigel Pharmaceuticals
Sarepta
AstraZeneca
ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity
Seeking Alpha
Wed, 04/3/13 - 10:55 am
ViroPharma
Dyax
Shire
Halozyme
generics
Pending Q4 Results: Dyax Partnerships Could Yield Sustained Growth For Investors
Seeking Alpha
Fri, 02/8/13 - 12:03 pm
Dyax
Dyax And ViroPharma: An Overview Of HAE Space
Seeking Alpha
Wed, 09/19/12 - 10:58 am
ViroPharma
Dyax
Cinryze
hereditary angiodema
Kalbitor
Dyax announces partnership with taiba for Kalbitor
The Fly on the Wall
Tue, 06/5/12 - 12:13 pm
Dyax
Kalbitor
hereditary angiodema
Middle East
taiba ME
Shire Enters a Crowded Market
Motley Fool
Thu, 09/1/11 - 11:37 am
Shire
Firazyr
Dyax
angioedema
CSL

Pages